INFLAMMATORY BOWEL DISEASES

metrics 2024

Innovating the future of gastrointestinal health.

Introduction

INFLAMMATORY BOWEL DISEASES is a premier journal published by Oxford University Press, Inc., dedicated to advancing research within the fields of gastroenterology and immunology. With an impressive impact factor reflecting its status as a Q1 category journal in both gastroenterology and immunology and allergy, it ranks 17th out of 167 in gastroenterology and 53rd out of 233 in immunology, underscoring its influence and authority within the scientific community. Since its inception in 1995 and continuing through to 2024, the journal has become an essential resource for researchers, healthcare professionals, and students, serving as a platform for the latest findings in the diagnosis, treatment, and management of inflammatory bowel diseases. While the journal operates under a subscription-based model, it is recognized for its rigorous peer-review process and commitment to publishing high-caliber, impactful studies that contribute significantly to understanding and treating these complex conditions.

Metrics 2024

SCIMAGO Journal Rank1.55
Journal Impact Factor4.50
Journal Impact Factor (5 years)4.70
H-Index172
Journal IF Without Self4.50
Eigen Factor0.02
Normal Eigen Factor3.51
Influence1.46
Immediacy Index0.70
Cited Half Life8.20
Citing Half Life6.40
JCI1.02
Total Documents6517
WOS Total Citations18601
SCIMAGO Total Citations72325
SCIMAGO SELF Citations5829
Scopus Journal Rank1.55
Cites / Document (2 Years)3.31
Cites / Document (3 Years)3.39
Cites / Document (4 Years)3.53

Metrics History

Rank 2024

Scopus

Gastroenterology in Medicine
Rank #17/167
Percentile 89.82
Quartile Q1
Immunology and Allergy in Medicine
Rank #53/233
Percentile 77.25
Quartile Q1

IF (Web Of Science)

GASTROENTEROLOGY & HEPATOLOGY
Rank 27/143
Percentile 81.50
Quartile Q1

JCI (Web Of Science)

GASTROENTEROLOGY & HEPATOLOGY
Rank 29/143
Percentile 79.72
Quartile Q1

Quartile History

Similar Journals

Intestinal Research

Championing Open Access for Intestinal Research Excellence
Publisher: KOREAN ASSOC STUDY INTESTINAL DISEASESISSN: 1598-9100Frequency: 4 issues/year

Intestinal Research is an influential open-access journal dedicated to advancing knowledge in the field of gastroenterology. Published by the Korean Association for the Study of Intestinal Diseases, this journal has been providing valuable insights into intestinal health since its inception in 2003. With an impressive impact factor and a current ranking of Q2 in the gastroenterology category, it is recognized among the top journals in its field, achieving a remarkable 82nd percentile in Scopus rankings. Based in South Korea, the journal's mission is to facilitate research and discussions on intestinal diseases, pathophysiology, innovative treatments, and advancements in care practices. By offering open access, Intestinal Research ensures that critical findings are readily available to researchers, healthcare professionals, and students alike, fostering global collaboration and sharing of knowledge. The journal accepts contributions that reflect the latest developments and foster deep understanding within the intestinal disease research community.

Gastrointestinal Disorders

Advancing Gastrointestinal Health Through Open Access Research
Publisher: MDPIISSN: Frequency: 4 issues/year

Gastrointestinal Disorders is a prominent open-access journal published by MDPI, based in Switzerland, that focuses on the latest research and innovations in the fields of gastroenterology, hepatology, and immunology. Since its inception in 2019, the journal has provided a vital platform for researchers and professionals to disseminate their findings, engaging with a global audience keen on advancing knowledge in gastrointestinal health. With a dedicated commitment to high-quality, peer-reviewed articles, Gastrointestinal Disorders has gained recognition in 2023, achieving Q3 status in gastroenterology and notable rankings in several other categories, including a respectable position in the quartiles for hepatology, immunology, and oncology. Despite its recent establishment, the journal has quickly become a valuable resource, facilitating open access to critical insights in the study of gastrointestinal diseases and their management, ensuring that emerging research is readily available to inform clinical practice and educate future professionals.

BMJ Open Gastroenterology

Connecting Researchers for a Healthier Gastrointestinal Future
Publisher: BMJ PUBLISHING GROUPISSN: 2054-4774Frequency: 1 issue/year

BMJ Open Gastroenterology is a premier open access journal published by the esteemed BMJ Publishing Group, focusing on the dynamic and evolving field of gastroenterology. Established in 2014, the journal has rapidly ascended in stature, reflected in its impressive 2023 Q1 ranking in gastroenterology and its position within the top 25% of journals in the category according to Scopus. With a mission to disseminate high-quality, peer-reviewed research with global significance, the journal provides a vital platform for researchers, professionals, and students alike to share their findings and advancements in gastrointestinal medicine. Operating from its headquarters in London, England, the journal's open access format ensures wide visibility and accessibility of cutting-edge research, making it an invaluable resource for those dedicated to improving patient care and driving innovation in gastroenterological sciences. By engaging with this journal, contributors and readers can stay at the forefront of critical developments in the field, fostering a collaborative environment for knowledge exchange.

International Journal of Rheumatic Diseases

Exploring innovations in rheumatic disease management.
Publisher: WILEYISSN: 1756-1841Frequency: 12 issues/year

The International Journal of Rheumatic Diseases, published by WILEY, serves as a crucial platform for disseminating high-quality research and advancements in the field of rheumatology. With an ISSN of 1756-1841 and an E-ISSN of 1756-185X, this journal has established itself within the academic community since its inception in 2008, and it is set to continue until at least 2024. Positioned in the Q3 category of rheumatology, the journal holds a significant rank of #38 out of 73 in its field according to Scopus, showcasing its growing influence despite the competitive environment. The absence of Open Access reflects a traditional scholarly publishing model, allowing for meticulous peer-review processes to ensure the rigor and reliability of published studies. This journal aims to foster innovative research, critical reviews, and clinical studies, thereby contributing to a deeper understanding of rheumatic diseases and enhancing patient care. The dedicated readership, including researchers, healthcare professionals, and students, will find valuable insights into the latest findings and methodologies relevant to rheumatology in the journal's comprehensive articles.

PRACTICAL GASTROENTEROLOGY

Fostering Excellence in Gastroenterology Education
Publisher: SHUGAR PUBLISHING INCISSN: 0277-4208Frequency: 12 issues/year

PRACTICAL GASTROENTEROLOGY is a distinguished journal dedicated to the field of gastroenterology, published by Shugar Publishing Inc in the United States. With an ISSN of 0277-4208, the journal serves as a pivotal resource for medical professionals, researchers, and students keen on staying abreast of the latest advancements and practical applications in gastrointestinal health. Although it does not currently operate under an Open Access model, it has been a respected publication since its inception, spanning significant years of research from 1989 to 2013 and resuming again from 2016 to 2023. Despite holding a current Q4 ranking in Gastroenterology with Scopus, its commitment to quality insights provides a platform for critical information dissemination, making it an essential read for those engaged in clinical practice and academic research. The journal’s objectives include addressing practical challenges in gastroenterology, bridging the gap between research and clinical implementation, and fostering ongoing education among practitioners in this dynamic field.

HPB

Empowering innovation in clinical practice and policy.
Publisher: ELSEVIER SCI LTDISSN: 1365-182XFrequency: 12 issues/year

HPB is a premier journal dedicated to advancing the fields of Gastroenterology and Hepatology, published by Elsevier Science Ltd. With an impressive impact factor reflective of its high-quality research output, HPB has earned its place as a Q1 journal in Gastroenterology and Q2 in Hepatology as of 2023. The journal, available in both print and electronic formats (ISSN: 1365-182X; E-ISSN: 1477-2574), serves as a vital platform for multidisciplinary research, encompassing clinical and experimental studies, aimed at improving patient care and outcomes related to liver and biliary diseases. Since its inception in 2000, HPB has published influential articles that have shaped practice and policy in the field. Located in the United Kingdom, at 125 London Wall, London EC2Y 5AS, the journal is poised to continue its mission of fostering innovation and collaboration among researchers, healthcare professionals, and academicians worldwide.

Clinical and Experimental Gastroenterology

Exploring the frontiers of gastroenterology for better patient outcomes.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-7023Frequency: 1 issue/year

Clinical and Experimental Gastroenterology is a prestigious Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of gastroenterology through rigorous research and innovative insights. With its ISSN 1178-7023, the journal has established a significant presence since its inception in 2008 and has been actively contributing to the academic landscape from New Zealand. The journal has attained a commendable Q2 rank in the Gastroenterology category as of 2023, placing it in the upper-tier percentile of similar journals. It currently ranks #57 out of 167 in the Scopus database, highlighting its relevance and impact in the field at the 66th percentile. Encompassing a wide range of topics within gastroenterology, the journal aims to foster discussion and disseminate findings that enhance clinical practices and patient care. Researchers, healthcare professionals, and students alike will find this journal an invaluable resource for cutting-edge research and developments in gastrointestinal health.

DIGESTIVE AND LIVER DISEASE

Transforming the landscape of liver disease research.
Publisher: ELSEVIER SCIENCE INCISSN: 1590-8658Frequency: 12 issues/year

DIGESTIVE AND LIVER DISEASE is a prominent journal published by Elsevier Science Inc, dedicated to advancing the field of gastroenterology and hepatology. With an ISSN of 1590-8658 and an E-ISSN of 1878-3562, this journal has established itself as a significant resource within the academic community, especially considering its Q2 ranking in both gastroenterology and hepatology categories as of 2023. Spanning from 2000 to 2024, the journal presents a diverse array of peer-reviewed articles, clinical studies, and review papers that explore the latest advancements and research findings in digestive and liver diseases. The journal's robust impact, reflected in its Scopus rankings—40th out of 167 in gastroenterology and 28th out of 82 in hepatology—highlights its critical role in shaping practices and understanding in these vital areas of medicine. With open access options available, DIGESTIVE AND LIVER DISEASE aims to make high-quality research accessible to a wider audience, thereby encouraging collaboration and innovation. Researchers, healthcare professionals, and students alike will find valuable insights into the complex mechanisms, diagnostics, and therapeutic strategies pertinent to digestive and liver health.

GUT

Empowering Clinicians and Researchers in Gastroenterology
Publisher: BMJ PUBLISHING GROUPISSN: 0017-5749Frequency: 12 issues/year

GUT is a premier journal in the field of gastroenterology, published by the esteemed BMJ Publishing Group. With a rich history dating back to 1960 and an impressive convergence of research expected to continue through 2024, GUT has established itself as a cornerstone of academic discourse in the gastrointestinal sciences. The journal boasts a remarkable impact factor, positioning it in the Q1 category for gastroenterology with an outstanding rank of #3 out of 167 in its Scopus ranking, reflecting its 98th percentile status among peers. Although it does not currently offer open access options, GUT remains dedicated to disseminating high-quality research, reviews, and clinical studies that advance the understanding of digestive health. Published in the United Kingdom, GUT serves as an essential resource for researchers, clinicians, and students aiming to stay at the forefront of innovations and developments in the field.

Canadian Journal of Gastroenterology and Hepatology

Championing Excellence in Gastroenterology and Hepatology
Publisher: HINDAWI LTDISSN: 2291-2789Frequency: 1 issue/year

Canadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.